Study title:
Q J Nucl Med Mol Imaging. 2006 Mar;50(1):68-77. Clinical impact of fluorine-18 fluorodeoxyglucose positron emission tomography in
cancer patients. A comparative study between dedicated camera and dual-head
coincidence gamma camera. Andrieux A, Switsers O, Chajari MH, Jacob JH, Delozier T, Gervais R, Allouache N,
Laurençon V, Henry-Amar M, Bardet S.
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Diagnosis [E01]
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: FLUDEOXYGLUCOSE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
Y
|